{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:22:52Z","timestamp":1790252572473,"version":"4.1.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Oxidative stress and dietary micronutrient imbalances have been implicated in prostate cancer (PCa) development and progression. Although flavonoids and antioxidants show promise in experimental models, evidence from population-based studies remains limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This research aimed to investigate the relationship between the consumption of antioxidants and flavonoids in the diet and the risk and survival of PCa, as well as to assess the potential of machine learning models in identifying significant dietary factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data from 2,629 male participants aged \u226540 years from National Health and Nutrition Examination Survey (NHANES) 2007\u20132010 were analyzed. Dietary intake was estimated using two 24-h recalls linked to the USDA Flavonoid Database. PCa status was self-reported. Survey-weighted logistic regression and Cox models evaluated associations with PCa prevalence and all-cause mortality, adjusting for demographic, lifestyle, and clinical covariates. Nine supervised machine learning models, including random forest (RF), were developed and validated. Shapley Additive Explanations (SHAP) values identified key predictors and visualized their effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 2,629 U.S. male participants from NHANES 2007\u20132010, 144 reported a history of PCa. Compared with non-cancer individuals, cases had lower intake of selenium, magnesium, quercetin, kaempferol, epicatechin, epigallocatechin, total flavones, and total flavonoids (all <jats:italic>P<\/jats:italic> &amp;lt; 0.05). Higher intake of selenium, magnesium, catechin, and myricetin was associated with reduced PCa risk in weighted regression models, with selenium remaining significant after multivariable adjustment [odds ratio (OR) = 0.50, 95% confidence interval (CI): 0.33\u20130.76]. Lower intake of selenium, magnesium, luteolin, quercetin, kaempferol, and total flavones was linked to increased mortality risk, and selenium independently predicted improved survival [hazard ratio (HR) = 0.69, 95% CI: 0.54\u20130.88]. The RF model showed superior predictive performance [area under the curve (AUC) = 0.740], identifying selenium, luteolin, total flavones, myricetin, catechin, and magnesium as key features. SHAP analysis revealed U-shaped associations for selenium, catechin, and myricetin, and dose-dependent protective effects for luteolin and magnesium.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results highlight selenium, magnesium, and select flavonoids as promising dietary factors in reducing PCa risk and improving prognosis. These insights support the development of evidence-based, individualized nutritional strategies and call for further mechanistic and clinical investigations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2025.1611848","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T14:28:37Z","timestamp":1751984917000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Dietary antioxidants and flavonoids are inversely associated with prostate cancer risk and mortality: evidence from NHANES and machine learning"],"prefix":"10.3389","volume":"12","author":[{"given":"Yanyang","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-shan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-po","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-quan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-cai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-ming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-liang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and prevention of prostate cancer.","volume":"4","author":"Gandaglia","year":"2021","journal-title":"Eur Urol Osncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2460785","DOI":"10.1001\/jamanetworkopen.2024.60785","article-title":"Race and ethnicity, lifestyle, diet, and survival in patients with prostate cancer.","volume":"8","author":"Wang","year":"2025","journal-title":"JAMA Netw Open."},{"key":"B3","doi-asserted-by":"publisher","first-page":"104675","DOI":"10.1016\/j.critrevonc.2025.104675","article-title":"Relationship between purinergic signalling and oxidative stress in prostate cancer: Perspectives for future therapy.","volume":"209","author":"Rossetto","year":"2025","journal-title":"Crit Rev Oncol Hematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"103490","DOI":"10.1016\/j.redox.2025.103490","article-title":"Desflurane attenuates renal ischemia-reperfusion injury by modulating ITGB1\/CD9 and reducing oxidative stress in tubular epithelial cells.","volume":"80","author":"Wu","year":"2025","journal-title":"Redox Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.3390\/ijms26062390","article-title":"The effects of iridin and irigenin on cancer: Comparison with well-known isoflavones in breast, prostate, and gastric cancers.","volume":"26","author":"Won","year":"2025","journal-title":"Int J Mol Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3390\/nu12041010","article-title":"Flavonoids as epigenetic modulators for prostate cancer prevention.","volume":"12","author":"Izzo","year":"2020","journal-title":"Nutrients."},{"key":"B7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.foodchem.2012.09.102","article-title":"Inhibition effects and induction of apoptosis of flavonoids on the prostate cancer cell line PC-3 in vitro.","volume":"138","author":"Xu","year":"2013","journal-title":"Food Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s11033-024-09567-6","article-title":"Recent advances in flavonoid compounds for the treatment of prostate cancer.","volume":"51","author":"Fang","year":"2024","journal-title":"Mol Biol Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/sj.pcan.4500845","article-title":"Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines.","volume":"9","author":"Haddad","year":"2006","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2174\/1871520615666151008122622","article-title":"Flavonoids with therapeutic potential in prostate cancer.","volume":"16","author":"Vue","year":"2016","journal-title":"Anticancer Agents Med Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.17849\/insm-47-01-31-39.1","article-title":"Random forest.","volume":"47","author":"Rigatti","year":"2017","journal-title":"J Insur Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e70056","DOI":"10.1111\/cts.70056","article-title":"Practical guide to SHAP analysis: Explaining supervised machine learning model predictions in drug development.","volume":"17","author":"Ponce-Bobadilla","year":"2024","journal-title":"Clin Transl Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"155598","DOI":"10.1016\/j.phymed.2024.155598","article-title":"Effects of natural extract interventions in prostate cancer: A systematic review and network meta-analysis.","volume":"129","author":"Huang","year":"2024","journal-title":"Phytomedicine."},{"key":"B14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/antiox11020251","article-title":"The role of selenium in pathologies: An updated review.","volume":"11","author":"Barchielli","year":"2022","journal-title":"antioxidants"},{"key":"B15","first-page":"7071","article-title":"Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line.","volume":"61","author":"Zhong","year":"2001","journal-title":"Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/ijms22031009","article-title":"Selenium compounds as novel potential anticancer agents.","volume":"22","author":"Radomska","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.7150\/thno.92119","article-title":"A novel selenium analog of HDACi-based twin drug induces apoptosis and cell cycle arrest via CDC25A to improve prostate cancer therapy.","volume":"14","author":"Shi","year":"2024","journal-title":"Theranostics."},{"key":"B18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/sj.bjc.6601974","article-title":"Status of selenium in prostate cancer prevention.","volume":"91","author":"Combs","year":"2004","journal-title":"Br J Cancer."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/pros.20329","article-title":"Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).","volume":"66","author":"Lee","year":"2006","journal-title":"Prostate."},{"key":"B20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.phymed.2013.07.018","article-title":"Use of selenium-silymarin mix reduces lower urinary tract symptoms and prostate specific antigen in men.","volume":"21","author":"Vostalova","year":"2013","journal-title":"Phytomedicine."},{"key":"B21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s41043-023-00423-0","article-title":"A narrative review on the role of magnesium in immune regulation, inflammation, infectious diseases, and cancer.","volume":"42","author":"Ashique","year":"2023","journal-title":"J Health Popul Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e18237","DOI":"10.1371\/journal.pone.0018237","article-title":"Blood magnesium, and the interaction with calcium, on the risk of high-grade prostate cancer.","volume":"6","author":"Dai","year":"2011","journal-title":"PLoS One."},{"key":"B23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ctrv.2009.01.003","article-title":"Magnesium and tumors: Ally or foe?","volume":"35","author":"Wolf","year":"2009","journal-title":"Cancer Treat Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2025.02.011","article-title":"Targeting mineral metabolism in cancer: Insights into signaling pathways and therapeutic strategies.","volume":"112","author":"Bhatnagar","year":"2025","journal-title":"Semin Cancer Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"9240","DOI":"10.3390\/ijms24119240","article-title":"Flavones: The apoptosis in prostate cancer of three flavones selected as therapeutic candidate models.","volume":"24","author":"Jeong","year":"2023","journal-title":"Int J Mol Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/ijms21020401","article-title":"Alleviation of multidrug resistance by flavonoid and non-flavonoid compounds in breast, lung, colorectal and prostate cancer.","volume":"21","author":"Costea","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4062\/biomolther.2019.034","article-title":"Flavonoids: Broad spectrum agents on chronic inflammation.","volume":"27","author":"Lim","year":"2019","journal-title":"Biomol Ther (Seoul)."},{"key":"B28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11033-024-10178-4","article-title":"Luteolin induces oxidative stress and apoptosis via dysregulating the cytoprotective Nrf2-Keap1-Cul3 redox signaling in metastatic castration-resistant prostate cancer cells.","volume":"52","author":"Eryilmaz","year":"2024","journal-title":"Mol Biol Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12929-022-00812-3","article-title":"Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer.","volume":"29","author":"Liu","year":"2022","journal-title":"J Biomed Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"111548","DOI":"10.1016\/j.biopha.2021.111548","article-title":"Emerging impact of quercetin in the treatment of prostate cancer.","volume":"138","author":"Ghafouri-Fard","year":"2021","journal-title":"Biomed Pharmacother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1530174","DOI":"10.3389\/fimmu.2025.1530174","article-title":"Association of composite dietary antioxidant index with high risk of prostate cancer in middle-aged and elderly men: Insights from NHANES.","volume":"16","author":"Jin","year":"2025","journal-title":"Front Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.3390\/nu15153298","article-title":"Dietary and serum antioxidants associated with prostate-specific antigen for middle-aged and older men.","volume":"15","author":"Lin","year":"2023","journal-title":"Nutrients."},{"key":"B33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jama.2008.864","article-title":"Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT).","volume":"301","author":"Lippman","year":"2009","journal-title":"JAMA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4801","DOI":"10.1038\/s41598-025-89506-y","article-title":"Association between magnesium depletion score and prostate cancer.","volume":"15","author":"Gong","year":"2025","journal-title":"Sci Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/aje\/kwu006","article-title":"Dietary flavonoid and proanthocyanidin intakes and prostate cancer risk in a prospective cohort of US men.","volume":"179","author":"Wang","year":"2014","journal-title":"Am J Epidemiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ctim.2018.05.002","article-title":"Association between dietary flavonoids intake and prostate cancer risk: A case-control study in Sicily.","volume":"39","author":"Reale","year":"2018","journal-title":"Complement Ther Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1158\/1055-9965.EPI-14-0322","article-title":"Adherence to dietary and lifestyle recommendations and prostate cancer risk in the prostate testing for cancer and treatment (ProtecT) trial.","volume":"23","author":"Er","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/nu13020496","article-title":"Dietary factors and prostate cancer development, progression, and reduction.","volume":"13","author":"Oczkowski","year":"2021","journal-title":"Nutrients."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1611848\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T14:28:38Z","timestamp":1751984918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1611848\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":38,"alternative-id":["10.3389\/fnut.2025.1611848"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1611848","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"article-number":"1611848"}}